AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

VERAPAMIL HYDROCHLORIDE

11 registrations across 2 African markets— 8 active

Markets with VERAPAMIL HYDROCHLORIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
ISOPTIN SR
TABLET, COATED; ORAL
🇿🇼ZimbabweABBOTT LABORATORIES SA (PTY) LTDactiveDec 2027
RAVAMIL SR 240 mg🇿🇦South AfricaMerck (Pty) LtdsuspendedAug 2025
ADCO-VERAPAMIL 40 mg TABLETS🇿🇦South AfricaAdcock Ingram LimitedsuspendedJul 2025
ADCO-VERAPAMIL 80 mg TABLETS🇿🇦South AfricaAdcock Ingram LimitedsuspendedJul 2025
VASOMIL - 80🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
VASOMIL - 40🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
VASOMIL - 120🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
VERAPAMIL 80 OETHMAAN🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
VERAPAMIL 120 OETHMAAN🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
VERAHEXAL 240 SR🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveJan 1900
VERAPAMIL 40 OETHMAAN🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900

VERAPAMIL HYDROCHLORIDE in Africa — Regulatory Overview

VERAPAMIL HYDROCHLORIDE is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.